---
title: "TJPC: Subsidiary TJPC HePing has obtained the drug registration certificate for Difluprednate Eye Drops"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254752001.md"
description: "TJPC announced that its subsidiary, Tianyao Heping Pharmaceutical Co., Ltd., has received the \"Drug Registration Certificate\" for Difluprednate Eye Drops issued by the National Medical Products Administration. This drug is primarily used to treat inflammation and pain related to eye surgery. Tianyao Heping has invested approximately 53.2734 million yuan in research and development for this project. Currently, Difluprednate Eye Drops is the first generic drug in the country. The global sales are projected to be USD 33 million and USD 24 million for 2023 and 2024, respectively"
datetime: "2025-08-27T07:35:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254752001.md)
  - [en](https://longbridge.com/en/news/254752001.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254752001.md)
generator: "portal-rs"
---

# TJPC: Subsidiary TJPC HePing has obtained the drug registration certificate for Difluprednate Eye Drops

TJPC announced that its subsidiary Tianyao Heping Pharmaceutical Co., Ltd. has received the "Drug Registration Certificate" for Difluprednate Eye Drops issued by the National Medical Products Administration. This drug is mainly used to treat inflammation and pain related to eye surgery. Tianyao Heping has invested approximately 53.2734 million yuan in research and development for this project. Currently, Difluprednate Eye Drops is the first generic drug in the country. The global sales are projected to be USD 33 million and USD 24 million for 2023 and 2024, respectively

### Related Stocks

- [600488.CN](https://longbridge.com/en/quote/600488.CN.md)

## Related News & Research

- [How Refrigerator Cyberattack Will Impact Colruyt Group (ENXTBR:COLR) Investors](https://longbridge.com/en/news/305581525.md)
- [Hyundai Elevator Earns Top SA1 Rating for Construction Safety Management](https://longbridge.com/en/news/305586598.md)
- [Canaccord Genuity Group Inc. (CF) Deal Offers $15.27 Per Share](https://longbridge.com/en/news/305585400.md)
- [Tennis-WTA chair is fully confident of financial recovery in 2027](https://longbridge.com/en/news/305578752.md)
- [What Qualys Buyers Were Betting On](https://longbridge.com/en/news/305582607.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**